Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition - Schedule of Revenue Recognition (Details)

v3.22.2
Revenue Recognition - Schedule of Revenue Recognition (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Disaggregation of Revenue [Line Items]        
Total revenue $ 5,200 $ 3,413 $ 10,231 $ 7,443
Functional Neurosurgery Navigation and Therapy - Disposable Products        
Disaggregation of Revenue [Line Items]        
Total revenue 1,798 1,861 3,661 3,779
Functional Neurosurgery Navigation and Therapy - Services        
Disaggregation of Revenue [Line Items]        
Total revenue 375 0 750 0
Functional Neurosurgery Navigation and Therapy        
Disaggregation of Revenue [Line Items]        
Total revenue 2,173 1,861 4,411 3,779
Biologics and Drug Delivery - Disposable Products        
Disaggregation of Revenue [Line Items]        
Total revenue 1,225 450 2,075 1,364
Biologics and Drug Delivery - Services        
Disaggregation of Revenue [Line Items]        
Total revenue 1,183 940 2,487 1,685
Biologics and Drug Delivery        
Disaggregation of Revenue [Line Items]        
Total revenue 2,408 1,390 4,562 3,049
Capital Equipment and Software - Systems and Software Products        
Disaggregation of Revenue [Line Items]        
Total revenue 434 52 884 382
Capital Equipment and Software - Services        
Disaggregation of Revenue [Line Items]        
Total revenue 185 110 374 233
Capital Equipment and Software        
Disaggregation of Revenue [Line Items]        
Total revenue $ 619 $ 162 $ 1,258 $ 615